EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells

Oncogene

Volumn 33, Issue 21, 2014, Pages 2737-2747

  Huang, J ^a   Xiao, D ^a   Li, G ^b   Ma, J ^b   Chen, P ^b   Yuan, W ^a   Hou, F ^a   Ge, J ^a   Zhong, M ^a   Tang, Y ^a   Xia, X ^c   Chen, Z ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

EphA2; epithelial mensenchymal transition; gastric cancer; Wnt catenin

Indexed keywords

BETA CATENIN; CYCLIN D1; EPHRIN RECEPTOR A2; MYC PROTEIN; NERVE CELL ADHESION MOLECULE; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; WNT PROTEIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GASTRIC CANCER CELL LINE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CANCER; TUMOR INVASION; UPREGULATION; WNT SIGNALING PATHWAY;

GASTROPODA;

ADULT; AGED; ANIMALS; ANTIGENS, CD; BETA CATENIN; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; RECEPTOR, EPHA2; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR BURDEN; UP-REGULATION; WNT SIGNALING PATHWAY;

EID: 84901502942     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.238     Document Type: Article

References (31)

1. Amit I Wides R Yarden Y. Evolvable signaling networks of receptor tyrosine kinases: relevance of robustness to malignancy and to cancer therapy. Mol Syst Biol 2007; 3: 151.
2. Sulman EP Tang XX Allen C Biege l JA Pleasure DE Brodeur GM et al. ECK a human EPH-related gene maps to 1p36.1 a common region of alteration in human cancers. Genomics 1997; 40: 371-374. (Pubitemid 27124104)
3. Baeten CI Hillen F Pauw els P de Bruine AP Baeten CG. Prognostic role of vasculogenic mimicry in colorectal cancer. Dis Colon Rectum 2009; 52: 2028-2035.
4. Brannan JM Dong W Prudkin L Behrens C Lotan R Bekele BN et al. Expression of the receptor tyrosine kinase EphA2 is increased in smokers and predicts poor survival in non-small cell lung cancer. Clin Cancer Res 2009; 15: 4423-4430.
5. Cui XD Lee MJ Yu GR Kim IH Yu HC Song EY et al. EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma. Int J Cancer 2010; 126: 940-949.
6. Li X Wang L Gu JW Li B Liu WP Wang YG et al. Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma. Tumour Biol 2010; 31: 477-488.
7. Merritt WM Kamat AA Hwang JY Bottsford-Miller J Lu C Lin YG et al. Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer. Cancer Biol Ther 2011; 10: 1306-1314.
8. Yuan WJ Ge J Chen ZK Wu SB Shen H Yang P et al. Over-expression of EphA2 and EphrinA-1 in human gastric adenocarcinoma and its prognostic value for postoperative patients. Dig Dis Sci 2009; 54: 2410-2417.
9. Tandon M Vemula SV Mittal SK. Emerging strategies for EphA2 receptor targeting for cancer therapeutics. Expert Opin Therap Targets 2011; 15: 31-51.
10. Udayakumar D Zhang G Ji Z Njauw CN Mroz P Tsao H. EphA2 is a critical oncogene in melanoma. Oncogene 2011; 30: 4921-4929.
11. Yuan W Chen Z Wu S Guo J Ge J Yang P et al. Silencing of EphA2 inhibits invasion of human gastric cancer SGC-7901 cells in vitro and in vivo. Neoplasma 2012; 59: 105-113.
12. Lu C Shahzad MM Wang H Landen CN Kim SW Allen J et al. EphA2 overexpression promotes ovarian cancer growth. Cancer Biol Ther 2008; 7: 1098-1103.
13. Thiery JP Acloque H Huang RY Nieto MA. Epithelial-mesenchymal transitions in development and disease Cell 2009 139 871-890.
14. Huber MA Kraut N Beug H. Molecular requirements for epithelial- mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17: 548-558. (Pubitemid 41267170)
15. Voulgari A Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: mechanisms markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta 2009; 1796: 75-90.
16. Kalluri R Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
17. Howard S Deroo T Fujita Y Itasaki N. A positive role of cadherin in Wnt/betacatenin signalling during epithelial-mesenchymal transition. PLoS One 2011; 6: e23899.
18. Sundaram MV. RTK/Ras/MAPK signaling. WormBook 2006; 1-19.
19. Yuan W Chen Z Wu S Ge J Chang S Wang X et al. Expression of EphA2 and E-cadherin in gastric cancer: corre lated with tumor progression and lymphogenous metastasis. Pathol Oncol Res 2009; 15: 473-478.
20. Huber O Bierkamp C Kemler R. Cadherins and catenins in development. Curr Opin Cell Biol 1996; 8: 685-691. (Pubitemid 26381726)
21. Taddei ML Parri M Angelucci A Bianchini F Marconi C Giannoni E et al. EphA2 induces metastatic growth regulating amoeboid motility and clonogenic potential in prostate c arcinoma cells. Mol Cancer Res 2011; 9: 149-160.
22. Macrae M Neve RM Rodriguez-Viciana P Haqq C Yeh J Chen C et al. A conditional feedback loop regulates Ras activity through EphA2. Cancer Cell 2005; 8: 111-118. (Pubitemid 41132740)
23. Menges CW McCance DJ. Constitutive activation of the Raf-MAPK pathway causes negative feedback inhibition of Ras-PI3K-AKT and cellular arrest through the EphA2 receptor. Oncogene 2008; 27: 2934-2940. (Pubitemid 351620455)
24. Miao H Wei BR Peehl DM Li Q Alexandrou T Schelling JR et al. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol 2001; 3: 527-530. (Pubitemid 32422092)
25. Pr att RL Kinch MS. Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade. Oncogene 2002; 21: 7690-7699. (Pubitemid 35398815)
26. Zhang G Njauw CN Park JM Naruse C Asano M Tsao H. EphA2 is an essential mediator of UV radiation-induced apoptosis. Cancer Res 2008; 68: 1691-1696. (Pubitemid 351416553)
27. Fukuyama R Niculaita R Ng KP Obusez E Sanchez J Kalady M et al. Mutated in colorectal cancer a putative tumor suppressor for serrated colorectal cancer selectively represses beta-catenin-dependent transcription. Oncogene 2008; 27: 6044-6055.
28. Malanchi I Peinado H Kassen D Hussenet T Metzger D Chambon P et al. Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature 2008; 452: 650-653. (Pubitemid 351483363)
29. Lovatt M Bijlmakers MJ. Stabilisation of beta-catenin downstream of T cell receptor signalling. PLoS One 2010; 5: pii: e12794.
30. Song S Mazurek N Liu C Sun Y Din g QQ Liu K et al. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity. Cancer Res 2009; 69: 1343-1349.
31. Wang Q Sun ZX Allgayer H Yang HS. Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells. Oncogene 2010; 29: 128-138.